Tag: FDA bioequivalence
-
FDA Bioequivalence Standards for NTI Drugs: Special Requirements Explained
Explore the FDA's strict bioequivalence standards for Narrow Therapeutic Index (NTI) drugs. Learn about the 90-111% limits, RSABE methodology, and why these rules matter for patient safety.
-
Generic Drug Quality Standards: What the FDA Requires and How Testing Works
Generic drugs must meet the same FDA standards as brand-name drugs for safety, strength, and effectiveness. Learn how bioequivalence testing, manufacturing rules, and inspections ensure quality-and why generics are trusted by millions.
-
Recent Advances in Bioequivalence Testing: Emerging Technologies Shaping Generic Drug Approval
Recent advances in bioequivalence testing, including AI-driven analysis, virtual models, and advanced imaging, are transforming how generic and biosimilar drugs are approved. These technologies reduce costs, speed up reviews, and improve accuracy-especially for complex formulations.